LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-18
Case ID: NM_001378414.1_c.1426C_T_20261118_002214
Framework: ACMG/AMP 2015
Variant classification summary

NM_001378414.1:c.1426C>T

HDAC4  · NP_001365343.1:p.(Pro476Ser)  · NM_001378414.1
GRCh37: chr2:240048259 G>A  ·  GRCh38: chr2:239126563 G>A
Gene: HDAC4 Transcript: NM_001378414.1
Final call
VUS
PM2 supporting PP3 supporting
All criteria require review: For research and educational purposes only.
Gene
HDAC4
Transcript
NM_001378414.1
Protein
NP_001365343.1:p.(Pro476Ser)
gnomAD AF
1.1154614106124998e-05 (v4.1)
ClinVar
OncoKB
Interpretation summary
Generated evidence synthesis
1
VUS: PM2 supporting reflects the variant's extremely low gnomAD filtering allele frequency.
2
VUS: PP3 supporting reflects REVEL 0.718 meeting the generic missense threshold.
Final determination: Under generic ACMG/AMP 2015 fallback rules, PM2 supporting plus PP3 supporting does not satisfy any pathogenic, likely pathogenic, benign, or likely benign combination, so the call is VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 N/A Not applicable: PVS1 requires a null variant (nonsense, frameshift, canonical splice, start-loss or stop-loss), and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PS1 Not met Not met: no established pathogenic HDAC4 variant causing p.Pro476Ser was identified, and the variant is absent from ClinVar.
generic_acmg_combination_rules
PS2 Not assessed Not assessed: no documented proband phenotype, family-history assessment, or confirmed maternity and paternity with both parents testing negative.
PS3 Not assessed Not assessed: no variant-specific validated in vitro or in vivo functional assay result is available for NM_001378414.1:c.1426C>T.
PS4 Not assessed Not assessed: gnomAD v4.1 shows 18/1,613,682 alleles, but no affected-case frequency, control comparison, OR/RR, or 95% CI is available.
gnomad_v4
PM1 Not assessed Not assessed: no complete HDAC4 domain assessment establishes that p.Pro476 lies in a critical domain without benign variation.
hotspots PMID:33537682
PM2 Met Met at supporting strength: gnomAD v4.1 grpmax FAF is 8.78e-06, below the <=0.0001 PM2 threshold.
gnomad_v4 gnomad_v2
PM3 Not assessed Not assessed: no documented recessive disease context or parent/offspring phase result establishes this variant in trans with a pathogenic variant.
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 Not met Not met: zero qualifying pathogenic alternate missense variants at HDAC4 residue 476 were identified for comparison with p.Pro476Ser.
pm5_candidates generic_acmg_combination_rules
PM6 Not assessed Not assessed: no affected-proband de novo observation or parental testing showing the variant absent without confirmed maternity and paternity.
PP1 Not assessed Not assessed: no affected relatives or family variant testing are documented, so co-segregation and informative meioses cannot be evaluated.
PP2 Not assessed Not assessed: the individual allele frequency is 1.11546e-05, but gene-wide benign-missense constraint and mechanism prevalence are unestablished.
gnomad_v4 PMID:33537682
PP3 Met Met at supporting strength: REVEL 0.718 meets the generic PP3 supporting threshold of >=0.644 for this missense variant.
revel
PP4 Not assessed Not assessed: no patient phenotype, family history, or disease-specific clinical description is available to evaluate PP4.
PP5 Not met Not met: ClinVar has no exact-variant record, with 0 submissions and 0 expert-panel submissions supporting pathogenicity.
BA1 Not met Not met: gnomAD v4.1 grpmax FAF is 8.78e-06 (0.000878%), below the >=0.05 BA1 threshold.
gnomad_v4 gnomad_v2
BS1 Not met Not met: gnomAD v4.1 grpmax FAF is 8.78e-06, far below the generic BS1 default threshold of >=0.01.
gnomad_v4 gnomad_v2
BS2 Not assessed Not assessed: no documented healthy adult carrying the variant and no inheritance or early-onset full-penetrance context is available.
gnomad_v4 gnomad_v2
BS3 Not assessed Not assessed: no variant-specific validated functional result shows that NM_001378414.1:c.1426C>T has no damaging effect.
BS4 Not assessed Not assessed: no tested affected relatives are documented, so lack of segregation and possible phenocopies cannot be evaluated.
BP1 Not assessed Not assessed: HDAC4 truncating/deletion disease and a missense disorder are documented, but predominance of truncating disease variants is unestablished.
PMID:20691407 PMID:33537682 generic_acmg_combination_rules
BP2 Not assessed Not assessed: no documented phase result shows this variant in trans or cis with a pathogenic variant in an affected individual.
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a missense variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 Not met Not met: REVEL 0.718 exceeds the generic BP4 supporting threshold of <=0.29, so the missense result is indeterminate for benign computational evidence.
revel
BP5 Not assessed Not assessed: no case-level evidence shows that the variant occurred with an alternate molecular basis for the disease.
BP6 Not met Not met: ClinVar has no exact-variant record, with 0 submissions and 0 expert-panel submissions supporting benignity.
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a missense variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.